Regulatory T cells: how do they suppress immune responses?

被引:674
作者
Sakaguchi, Shimon [1 ,2 ]
Wing, Kajsa [1 ]
Onishi, Yasushi [1 ]
Prieto-Martin, Paz [1 ]
Yamaguchi, Tomoyuki [1 ]
机构
[1] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Sakyo Ku, Kyoto 6068507, Japan
[2] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan
关键词
IMMUNOLOGICAL SELF-TOLERANCE; TGF-BETA; MEDIATED SUPPRESSION; AUTOIMMUNE-DISEASE; CUTTING EDGE; TARGET GENES; GRANZYME-B; IN-VITRO; INTERLEUKIN-2; FOXP3;
D O I
10.1093/intimm/dxp095
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Regulatory T cells (Tregs), either natural or induced, suppress a variety of physiological and pathological immune responses. One of the key issues for understanding Treg function is to determine how they suppress other lymphocytes at the molecular level in vivo and in vitro. Here we propose that there may be a key suppressive mechanism that is shared by every forkhead box p3 (Foxp3)(+) Treg in vivo and in vitro in mice and humans. When this central mechanism is abrogated, it causes a breach in self-tolerance and immune homeostasis. Other suppressive mechanisms may synergistically operate with this common mechanism depending on the environment and the type of an immune response. Further, Treg-mediated suppression is a multi-step process and impairment or augmentation of each step can alter the ultimate effectiveness of Treg-mediated suppression. These findings will help to design effective ways for controlling immune responses by targeting Treg suppressive functions.
引用
收藏
页码:1105 / 1111
页数:7
相关论文
共 78 条
[1]   CD4+FoxP3+ regulatory T cells confer infectious tolerance in a TGF-β-dependent manner [J].
Andersson, John ;
Tran, Dat Q. ;
Pesu, Marko ;
Davidson, Todd S. ;
Ramsey, Heather ;
O'Shea, John J. ;
Shevach, Ethan M. .
JOURNAL OF EXPERIMENTAL MEDICINE, 2008, 205 (09) :1975-1981
[2]   Interleukin 2-dependent mechanisms of tolerance and immunity in vivo [J].
Antony, Paul A. ;
Paulos, Chrystal M. ;
Ahmadzadeh, Mojgan ;
Akpinarli, Akgul ;
Palmer, Douglas C. ;
Sato, Noriko ;
Kaiser, Andrew ;
Heinrichs, Christian ;
Klebanoff, Christopher A. ;
Tagaya, Yutaka ;
Restifo, Nicholas P. .
JOURNAL OF IMMUNOLOGY, 2006, 176 (09) :5255-5266
[3]   An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation [J].
Asseman, C ;
Mauze, S ;
Leach, MW ;
Coffman, RL ;
Powrie, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) :995-1003
[4]  
Bachmann MF, 1999, J IMMUNOL, V163, P1128
[5]  
Bachmann MF, 2001, EUR J IMMUNOL, V31, P450, DOI 10.1002/1521-4141(200102)31:2<450::AID-IMMU450>3.0.CO
[6]  
2-X
[7]   Natural regulatory T cells in infectious disease [J].
Belkaid, Y ;
Rouse, BT .
NATURE IMMUNOLOGY, 2005, 6 (04) :353-360
[8]   Cyclic adenosine monophosphate is a key component of regulatory T cell mediated suppression [J].
Bopp, Tobias ;
Becker, Christian ;
Klein, Matthias ;
Klein-Hessling, Stefan ;
Palmetshofer, Alois ;
Serfling, Edgar ;
Heib, Valeska ;
Becker, Marc ;
Kubach, Jan ;
Schmitt, Steffen ;
Stoll, Sabine ;
Schild, Hansjoerg ;
Staege, Martin S. ;
Stassen, Michael ;
Jonuleit, Helmut ;
Schmitt, Edgar .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (06) :1303-1310
[9]   IL-2 receptor β-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells [J].
Burchill, Matthew A. ;
Yang, Jianying ;
Vogtenhuber, Christine ;
Blazar, Bruce R. ;
Farrar, Michael A. .
JOURNAL OF IMMUNOLOGY, 2007, 178 (01) :280-290
[10]   Granzyme B and perforin are important for regulatory T cell-mediated suppression of tumor clearance [J].
Cao, Xuefang ;
Cai, Sheng F. ;
Fehniger, Todd A. ;
Song, Jiling ;
Collins, Lynne I. ;
Piwnica-Worms, David R. ;
Ley, Timothy J. .
IMMUNITY, 2007, 27 (04) :635-646